APO RESEARCH · REPORT
Autism Spectrum Disorder Diagnosis and Therapeutics
Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities.
Product & engineering
Understand the product.
Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities.
Selected research
Industry Growth & Trends
Global Autism Spectrum Disorder Diagnosis and Therapeutics Industry Growth and Trends Forecast to 2032
Market perspective
Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities.
According to APO Research, the global Autism Spectrum Disorder Diagnosis and Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Autism Spectrum Disorder Diagnosis and Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Autism Spectrum Disorder Diagnosis and Therapeutics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Autism Spectrum Disorder Diagnosis and Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Autism Spectrum Disorder Diagnosis and Therapeutics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Autism Spectrum Disorder Diagnosis and Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Autism Spectrum Disorder Diagnosis and Therapeutics Market by Company
Otsuka
AstraZeneca
Pfizer
Eli Lilly
Johnson & Johnson
Autism Spectrum Disorder Diagnosis and Therapeutics Segment by Type
Autistic Disorder
Asperger Syndrome
Childhood Disintegrative Disorder
Others
Autism Spectrum Disorder Diagnosis and Therapeutics Segment by Application
Children and Teenagers
Adults
Autism Spectrum Disorder Diagnosis and Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autism Spectrum Disorder Diagnosis and Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autism Spectrum Disorder Diagnosis and Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autism Spectrum Disorder Diagnosis and Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Autism Spectrum Disorder Diagnosis and Therapeutics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Autistic Disorder
- Asperger Syndrome
- Childhood Disintegrative Disorder
- Others
Applications
- Children and Teenagers
- Adults
Companies covered
- Otsuka
- AstraZeneca
- Pfizer
- Eli Lilly
- Johnson & Johnson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Region (2021-2032)
- 1.4.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Region (2021-2026)
- 1.4.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Region (2027-2032)
- 1.5 Key Regions Autism Spectrum Disorder Diagnosis and Therapeutics Market Size (2021-2032)
- 1.5.1 North America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate (2021-2032)
2 Autism Spectrum Disorder Diagnosis and Therapeutics Market by Type
- 2.1 Type Introduction
- 2.1.1 Autistic Disorder
- 2.1.2 Asperger Syndrome
- 2.1.3 Childhood Disintegrative Disorder
- 2.1.4 Others
- 2.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Type
- 2.2.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Regions
- 2.3.1 North America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Breakdown by Type (2021-2026)
3 Autism Spectrum Disorder Diagnosis and Therapeutics Market by Application
- 3.1 Type Introduction
- 3.1.1 Children and Teenagers
- 3.1.2 Adults
- 3.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Application
- 3.2.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Regions
- 3.3.1 North America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Autism Spectrum Disorder Diagnosis and Therapeutics Industry Trends
- 4.2 Autism Spectrum Disorder Diagnosis and Therapeutics Industry Drivers
- 4.3 Autism Spectrum Disorder Diagnosis and Therapeutics Industry Opportunities and Challenges
- 4.4 Autism Spectrum Disorder Diagnosis and Therapeutics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Autism Spectrum Disorder Diagnosis and Therapeutics Revenue (2021-2026)
- 5.2 Global Autism Spectrum Disorder Diagnosis and Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Autism Spectrum Disorder Diagnosis and Therapeutics Key Company Headquarters & Area Served
- 5.4 Global Autism Spectrum Disorder Diagnosis and Therapeutics Company, Product Type & Application
- 5.5 Global Autism Spectrum Disorder Diagnosis and Therapeutics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Autism Spectrum Disorder Diagnosis and Therapeutics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Autism Spectrum Disorder Diagnosis and Therapeutics Players Market Share by Revenue in 2025
- 5.6.3 2025 Autism Spectrum Disorder Diagnosis and Therapeutics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Otsuka
- 6.1.1 Otsuka Company Information
- 6.1.2 Otsuka Business Overview
- 6.1.3 Otsuka Autism Spectrum Disorder Diagnosis and Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Otsuka Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
- 6.1.5 Otsuka Recent Developments
- 6.2 AstraZeneca
- 6.2.1 AstraZeneca Company Information
- 6.2.2 AstraZeneca Business Overview
- 6.2.3 AstraZeneca Autism Spectrum Disorder Diagnosis and Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 AstraZeneca Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
- 6.2.5 AstraZeneca Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Autism Spectrum Disorder Diagnosis and Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Pfizer Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 Eli Lilly
- 6.4.1 Eli Lilly Company Information
- 6.4.2 Eli Lilly Business Overview
- 6.4.3 Eli Lilly Autism Spectrum Disorder Diagnosis and Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Eli Lilly Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
- 6.4.5 Eli Lilly Recent Developments
- 6.5 Johnson & Johnson
- 6.5.1 Johnson & Johnson Company Information
- 6.5.2 Johnson & Johnson Business Overview
- 6.5.3 Johnson & Johnson Autism Spectrum Disorder Diagnosis and Therapeutics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Johnson & Johnson Autism Spectrum Disorder Diagnosis and Therapeutics Product Portfolio
- 6.5.5 Johnson & Johnson Recent Developments
7 North America
- 7.1 North America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2021-2026)
- 7.3 North America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2021-2026)
- 8.3 Europe Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2021-2026)
- 10.3 South America Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Autism Spectrum Disorder Diagnosis and Therapeutics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Autism Spectrum Disorder Diagnosis and Therapeutics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst